Kimialys: Funding, Investors & Team (Oct 2026)
Kimialys develops and sells proprietary and patented surface chemistry for biosensors, increasing their sensitivity and specificity to deliver reliable, rapid, and cost-effective diagnostic tests. It was founded in 2020 by Cyril Gilbert and Claude Nogues in Paris, Ile-de-France, France.
Kimialys has raised $4.2M across 1 funding round on record, the most recent a Seed of $4.2M announced in Dec 2025.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kimialys Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Kimialys Funding Rounds
Kimialys Founders and Leadership Team
Contact details for the Kimialys team: 1 of 1 has an email address on file.
Start 14-day free trial →Kimialys Funding Compared to Other Biotechnology Startups
Kimialys' latest round of $4.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kimialys in Biotechnology and Paris
Companies Similar to Kimialys
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs…
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
Kimialys Funding FAQs
What does Kimialys do?
Kimialys develops and sells proprietary and patented surface chemistry for biosensors, increasing their sensitivity and specificity to deliver reliable, rapid, and cost-effective diagnostic tests. It was founded in 2020 by Cyril Gilbert and Claude Nogues in Paris, Ile-de-France, France.
How much funding has Kimialys raised?
Kimialys has raised $4.2M across 1 round on record. The most recent is a Seed of $4.2M announced in Dec 2025.
When did Kimialys last raise funding?
Kimialys' most recent funding round on record is a Seed of $4.2M, announced in Dec 2025.
Who founded Kimialys?
FundedIQ lists Claude Nogues (Founder) at Kimialys.
Where is Kimialys headquartered?
Kimialys is based in Paris, Ile-de-France, France.
How many employees does Kimialys have?
Kimialys is in the 11-50 employee band.
How does Kimialys' funding compare to other Biotechnology startups?
Kimialys' latest round of $4.2M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Kimialys Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kimialys is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.